BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32011681)

  • 1. CD177 Enhances the Detection of Myelodysplastic Syndrome by Flow Cytometry.
    Alayed K; Meyerson JB; Osei ES; Blidaru G; Schlegelmilch J; Johnson M; Meyerson HJ
    Am J Clin Pathol; 2020 Mar; 153(4):554-565. PubMed ID: 32011681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased CD177
    Alayed K; Meyerson HJ
    Leuk Res; 2022 Jan; 112():106752. PubMed ID: 34896936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined utility of CD177, P53, CD105 and c-kit immunohistochemical stains improves the detection of myelodysplastic syndrome.
    Aladily TN; Obiedat S; Bustami N; Alhesa A; Altantawi AM; Khader M; Mansour AT
    Ann Diagn Pathol; 2021 Dec; 55():151810. PubMed ID: 34482217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD177 expression on neutrophils: in search of a clonal assay for myeloid neoplasia by flow cytometry.
    Meyerson HJ; Osei E; Schweitzer K; Blidaru G; Edinger A; Balog A
    Am J Clin Pathol; 2013 Nov; 140(5):658-69. PubMed ID: 24124144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
    Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
    Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
    Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
    Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
    Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
    Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
    Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes.
    Mestrum SGC; Cremers EMP; de Wit NCJ; Drent RJM; Ramaekers FCS; Hopman AHN; Leers MPG
    Leuk Res; 2022 Feb; 113():106789. PubMed ID: 35101793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory signature in acute-on-chronic liver failure includes increased expression of granulocyte genes ELANE, MPO and CD177.
    Saha R; Pradhan SS; Shalimar ; Das P; Mishra P; Singh R; Sivaramakrishnan V; Acharya P
    Sci Rep; 2021 Sep; 11(1):18849. PubMed ID: 34552111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
    Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients.
    Demaret J; Venet F; Plassais J; Cazalis MA; Vallin H; Friggeri A; Lepape A; Rimmelé T; Textoris J; Monneret G
    Immunol Lett; 2016 Oct; 178():122-30. PubMed ID: 27568821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.
    Moon HW; Huh JW; Lee M; Hong KS; Chung WS
    Korean J Lab Med; 2010 Apr; 30(2):97-104. PubMed ID: 20445324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
    Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience.
    Majcherek M; Kiernicka-Parulska J; Mierzwa A; Barańska M; Matuszak M; Lewandowski K; Komarnicki M; Czyż A
    Scand J Immunol; 2021 Aug; 94(2):e13028. PubMed ID: 33577137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.
    Shameli A; Dharmani-Khan P; Luider J; Auer I; Shabani-Rad MT
    Cytometry B Clin Cytom; 2021 Sep; 100(5):574-589. PubMed ID: 33369070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India.
    Dhingra G; Dass J; Arya V; Gupta N; Saraf A; Langer S; Aggarwal S; Kotwal J; Bhargava M
    Indian J Med Res; 2020 Sep; 152(3):254-262. PubMed ID: 33107485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
    Cremers EM; Westers TM; Alhan C; Cali C; Visser-Wisselaar HA; Chitu DA; van der Velden VH; Te Marvelde JG; Klein SK; Muus P; Vellenga E; de Greef GE; Legdeur MC; Wijermans PW; Stevens-Kroef MJ; Silva-Coelho PD; Jansen JH; Ossenkoppele GJ; van de Loosdrecht AA;
    Haematologica; 2017 Feb; 102(2):320-326. PubMed ID: 27658438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.